首页> 美国卫生研究院文献>Nucleic Acids Research >Regulostat Inferelator: a novel network biology platform to uncover molecular devices that predetermine cellular response phenotypes
【2h】

Regulostat Inferelator: a novel network biology platform to uncover molecular devices that predetermine cellular response phenotypes

机译:Regulostat Inferelator:一种新型的网络生物学平台可揭示预先确定细胞反应表型的分子装置

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

With the emergence of genome editing technologies and synthetic biology, it is now possible to engineer genetic circuits driving a cell's phenotypic response to a stressor. However, capturing a continuous response, rather than simply a binary ‘on’ or ‘off’ response, remains a bioengineering challenge. No tools currently exist to identify gene candidates responsible for predetermining and fine-tuning cell response phenotypes. To address this gap, we devised a novel Regulostat Inferelator (RSI) algorithm to decipher intrinsic molecular devices or networks that predetermine cellular phenotypic responses. The RSI algorithm is designed to extract gene expression patterns from basal transcriptomic data in order to identify ‘regulostat’ constituent gene pairs, which exhibit rheostat-like mode-of-cooperation capable of fine-tuning cellular response. Our proof-of-concept study provides computational evidence for the existence of regulostats and that these networks predetermine cellular response prior to exposure to a stressor or drug. In addition, our work, for the first time, provides evidence of context-specific, drug–regulostat interactions in predetermining drug response phenotypes in cancer cells. Given RSI-inferred regulostat networks offer insights for prioritizing gene candidates capable of rendering a resistant phenotype sensitive to a given drug, we envision that this tool will be of great value in bioengineering and medicine.
机译:随着基因组编辑技术和合成生物学的出现,现在有可能工程化驱动细胞对应激源表型反应的遗传电路。但是,捕获持续的响应,而不是简单的二进制“打开”或“关闭”响应,仍然是生物工程学的挑战。当前尚无工具来鉴定负责预定和微调细胞反应表型的基因候选物。为了解决这个空白,我们设计了一种新颖的Regulostat Inferelator(RSI)算法来解密预先确定细胞表型反应的内在分子设备或网络。 RSI算法旨在从基础转录组学数据中提取基因表达模式,以鉴定“ regulostat”组成基因对,这些基因对表现出类似变阻器的合作模式,能够微调细胞反应。我们的概念验证研究为调节剂的存在提供了计算证据,并且这些网络在暴露于应激源或药物之前就可以预先确定细胞反应。此外,我们的工作首次为预先确定癌细胞中药物反应表型的特定情境,药物-调节剂相互作用提供了证据。鉴于RSI推断的regulostat网络可为优先考虑能够使耐药表型对给定药物敏感的基因候选者提供见解,因此我们认为该工具在生物工程和医学中将具有重要价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号